MGX · Metagenomi Therapeutics, Inc. · Debt
Market Cap
$31.40M
Shares
37.78M
Volume · Oct 20
94.11K
Avg daily vol (3M)
156.43K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 6,235,000 | 10-Q filed 2026-08-10 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 31,485,000 | 10-Q filed 2026-08-10 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.